Max Drawdown (5Y) Chart

Historical Max Drawdown (5Y) Data

View and export this data back to 1998. Start Trial.
Date Value
September 30, 2026 76.87%
August 31, 2026 76.87%
July 31, 2026 76.87%
June 30, 2026 76.87%
May 31, 2026 76.87%
April 30, 2026 76.87%
March 31, 2026 76.87%
February 28, 2026 76.87%
January 31, 2026 63.43%
December 31, 2025 63.43%
November 30, 2025 63.43%
October 31, 2025 63.43%
September 30, 2025 63.43%
August 31, 2025 63.43%
July 31, 2025 63.43%
June 30, 2025 63.43%
May 31, 2025 63.43%
April 30, 2025 60.49%
March 31, 2025 49.45%
February 28, 2025 47.24%
January 31, 2025 45.92%
December 31, 2024 45.92%
November 30, 2024 45.92%
October 31, 2024 43.85%
September 30, 2024 43.85%
Date Value
August 31, 2024 43.85%
July 31, 2024 43.85%
June 30, 2024 43.85%
May 31, 2024 43.85%
April 30, 2024 43.85%
March 31, 2024 43.85%
February 29, 2024 43.85%
January 31, 2024 43.85%
December 31, 2023 43.85%
November 30, 2023 43.85%
October 31, 2023 43.85%
September 30, 2023 43.85%
August 31, 2023 43.85%
July 31, 2023 43.85%
June 30, 2023 43.85%
May 31, 2023 43.85%
April 30, 2023 43.85%
March 31, 2023 43.85%
February 28, 2023 43.85%
January 31, 2023 43.85%
December 31, 2022 43.85%
November 30, 2022 43.85%
October 31, 2022 43.85%
September 30, 2022 40.83%
August 31, 2022 36.29%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
IQVIA Holdings, Inc. 51.52%
Medpace Holdings, Inc. 42.87%
Proteome Sciences Plc 93.95%
Champions Oncology, Inc. 78.53%
Avantor, Inc. 83.16%